284 related articles for article (PubMed ID: 30007969)
1. Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β.
Zhou L; Sun X; Huang Z; Zhou T; Zhu X; Liu Y; Wang J; Cheng B; Li M; He C; Liu X
Cell Physiol Biochem; 2018; 48(1):263-273. PubMed ID: 30007969
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Liu N; Chen L; Cai N
Int J Clin Exp Pathol; 2015; 8(5):4990-8. PubMed ID: 26191192
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.
Roberts WG; Whalen PM; Soderstrom E; Moraski G; Lyssikatos JP; Wang HF; Cooper B; Baker DA; Savage D; Dalvie D; Atherton JA; Ralston S; Szewc R; Kath JC; Lin J; Soderstrom C; Tkalcevic G; Cohen BD; Pollack V; Barth W; Hungerford W; Ung E
Cancer Res; 2005 Feb; 65(3):957-66. PubMed ID: 15705896
[TBL] [Abstract][Full Text] [Related]
4. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H
Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373
[TBL] [Abstract][Full Text] [Related]
5. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C
Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
[TBL] [Abstract][Full Text] [Related]
8. Sipjeondaebo-tang, a traditional herbal formula, inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Lee YM; Kim CS; Sohn E; Jo K; Lim HR; Kim SK; Kim JS; Kim J
Tohoku J Exp Med; 2014 Nov; 234(3):229-36. PubMed ID: 25365937
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic effect of metformin in mouse oxygen-induced retinopathy is mediated by reducing levels of the vascular endothelial growth factor receptor Flk-1.
Joe SG; Yoon YH; Choi JA; Koh JY
PLoS One; 2015; 10(3):e0119708. PubMed ID: 25785990
[TBL] [Abstract][Full Text] [Related]
10. Predicting Effectiveness of Imatinib Mesylate in Tumors Expressing Platelet-Derived Growth Factors (PDGF-AA, PDGF-BB), Stem Cell Factor Ligands and Their Respective Receptors (PDGFR-α, PDGFR-β, and c-kit).
Moawad EY
J Gastrointest Cancer; 2015 Sep; 46(3):272-83. PubMed ID: 25985771
[TBL] [Abstract][Full Text] [Related]
11. Rifampicin inhibits the retinal neovascularization in vitro and in vivo.
Chikaraishi Y; Matsunaga N; Shimazawa M; Hara H
Exp Eye Res; 2008 Jan; 86(1):131-7. PubMed ID: 18031740
[TBL] [Abstract][Full Text] [Related]
12. CB-12181, a new azasugar-based matrix metalloproteinase/tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular endothelial growth factor-induced angiogenesis in vitro and retinal neovascularization in vivo.
Chikaraishi Y; Shimazawa M; Yokota K; Yoshino K; Hara H
Curr Neurovasc Res; 2009 Aug; 6(3):140-7. PubMed ID: 19534723
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic and anti-inflammatory effects of CD200-CD200R1 axis in oxygen-induced retinopathy mice model.
Hu Y; Wei T; Gao S; Cheng Q
Inflamm Res; 2019 Nov; 68(11):945-955. PubMed ID: 31444514
[TBL] [Abstract][Full Text] [Related]
14. β-LGND2, an ERβ selective agonist, inhibits pathologic retinal neovascularization.
Giddabasappa A; Eswaraka JR; Barrett CM; Bauler MN; Wu Z; Yepuru M; Miller DD; Dalton JT
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):5066-75. PubMed ID: 22714897
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy.
Kolibabka M; Dietrich N; Klein T; Hammes HP
Diabetologia; 2018 Nov; 61(11):2412-2421. PubMed ID: 30097694
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor receptor-beta constitutive activity promotes angiogenesis in vivo and in vitro.
Magnusson PU; Looman C; Ahgren A; Wu Y; Claesson-Welsh L; Heuchel RL
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2142-9. PubMed ID: 17656670
[TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.
McGary EC; Onn A; Mills L; Heimberger A; Eton O; Thomas GW; Shtivelband M; Bar-Eli M
J Invest Dermatol; 2004 Feb; 122(2):400-5. PubMed ID: 15009722
[TBL] [Abstract][Full Text] [Related]
18. Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy.
Lee YM; Lee YR; Kim CS; Jo K; Sohn E; Kim JS; Kim J
Int J Mol Sci; 2015 Dec; 16(12):29900-10. PubMed ID: 26694358
[TBL] [Abstract][Full Text] [Related]
19. Novel multi-targeted inhibitors suppress ocular neovascularization by regulating unique gene sets.
Yin X; Lin X; Ren X; Yu B; Liu L; Ye Z; Chen Q; Lee C; Lu W; Yu D; Li X
Pharmacol Res; 2019 Aug; 146():104277. PubMed ID: 31112749
[TBL] [Abstract][Full Text] [Related]
20. Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.
Song HB; Jun HO; Kim JH; Fruttiger M; Kim JH
Cell Calcium; 2015 Feb; 57(2):101-8. PubMed ID: 25605522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
